Is Nvidia Stock Too Cheap to Ignore Right Now?

Nvidia shares are down 14% from their May all-time high, and the stock has lagged the broader market despite business improving. The article argues Nvidia is getting cheaper on analyst profit targets—about 16x next year’s earnings versus 23x this fiscal year—while pointing to strong recent fundamentals including an 85% fiscal Q1 revenue jump and three consecutive quarters of accelerating revenue. It also frames headwinds (e.g., China-focused AI competition like DeepSeek and Chinese trade restrictions) as potentially overstated given rising client demand and improving analyst estimates.

Analysis

The market is treating NVDA like a crowded consensus trade, but the more important variable is that estimate revisions are still moving up faster than the multiple is moving down. That usually means the stock is not being priced off current fundamentals; it is being priced off a belief that the capex cycle is already peaking. We think that is too early: hyperscaler spending and enterprise AI deployments are still in the phase where utilization, not unit demand, determines the next leg of revenue.

The real second-order effect is that improving inference efficiency does not necessarily hurt NVDA; it can expand the addressable workload by lowering cost per token and unlocking marginal use cases. The more immediate beneficiaries of the rotation are likely the "pick-and-shovel" neighbors — memory, networking, advanced packaging, and foundry capacity — but many of those names have already started to discount the same theme, so a broad second-derivative basket may be less attractive than owning the core platform leader. The clearest loser is the cohort of custom-silicon and software efficiency narratives that need a near-term slowdown in NVIDIA demand to justify their relative re-rating.

Over the next 1-3 months, the key risk is not a collapse in demand but a pause in estimate revisions or a guide that confirms growth is decelerating from a very high base. That would keep the stock range-bound even if fundamentals remain strong. Over 6-18 months, the thesis breaks only if enterprise ROI on AI stalls, export restrictions materially widen, or hyperscalers shift capex away from general-purpose acceleration toward more bespoke silicon than currently modeled.

Key Decisions for Investors

• Long NVDA / short AMD into the next earnings cycle: use the current valuation gap as a relative-value expression of 'best-in-class execution vs catch-up story.' Risk/reward improves if NVDA guides numbers up while AMD remains narrative-driven; thesis is wrong if AMD wins incremental share in datacenter attach or NVDA gross margins compress faster than expected.
• Initiate a tactical long in SMH or SOXX only on a pullback, not on strength: if the rotation is just factor-driven, the basket should work once the market stops debating leadership. Prefer scaling in on a 3%-5% broader semi weakness; cut if the ETF underperforms QQQ for two consecutive weeks after NVDA reports.
• Use NVDA pullbacks near implied-support levels for call spreads rather than stock if positioning remains crowded: upside is still driven by revisions, but the near-term can be noisy. A 1-3 month call spread captures upside to the next guide with defined downside; invalidate if next-quarter revenue or margin guide comes in below current consensus by more than ~2%.
• Watch-list alert for MU and the HBM complex: if NVDA demand is still expanding, memory remains the cleaner second-order beneficiary than the generic AI basket. If DRAM pricing or HBM commentary rolls over, that is an early warning that the broader AI capex chain is cooling before NVDA itself cracks.
• No aggressive short in NVDA here; the better contrarian short is any AI laggard trading on the assumption that NVDA demand is peaking. If you want bearish exposure, express it in names with weaker operating leverage and less pricing power rather than the platform leader.